Read + Share
Shi SJ, Han DH, Zhang JL, Li Y, et al. VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate
cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization. Int J Oncol 2023;62:34.
PMID: 36734275
|
 |
|
Shi SJ, Han DH, Zhang JL, Li Y, et al. VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate
cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization. Int J Oncol 2023;62:34.
PMID: 36734275
|
|
|
|